SCHEMBL7180753

SCHEMBL7180753

CCOc1ccc(OCC)c(/C=C/C(=O)c2ccc(OC)cc2)c1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.69
MAOB P27338 2/20 0.66
DPP4 P27487 4/20 0.63
LMNA P02545 4/20 0.62
MAPT P10636 4/20 0.62
KDM4E B2RXH2 3/20 0.62
SMN1; SMN2 Q16637 3/20 0.62
ATM Q13315 2/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
CYP1A1 P04798 1/20 0.61
CYP1B1 Q16678 1/20 0.61
TNFRSF1A P19438 2/20 0.60
GABRA3 P34903 1/20 0.60
GABRA2 P47869 1/20 0.60
GABRB2 P47870 1/20 0.60
ALDH1A1 P00352 1/20 0.59
PTPN1 P18031 2/20 0.58
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7180758 1.00 ABCG2 (0.69) ABCG2MAOBDPP4LMNAMAPT
SCHEMBL7192505 0.93 DPP4 (0.63) ABCG2MAOBDPP4LMNAMAPT
SCHEMBL7192513 0.93 DPP4 (0.63) ABCG2MAOBDPP4LMNAMAPT
SCHEMBL9115423 0.90 CYP1A1 (0.71) ABCG2MAOBDPP4LMNAMAPT
SCHEMBL9115417 0.90 CYP1A1 (0.71) ABCG2MAOBDPP4LMNAMAPT
SCHEMBL7190767 0.90 ABCG2 (0.82) ABCG2MAOBDPP4LMNAMAPT
SCHEMBL7190768 0.90 ABCG2 (0.82) ABCG2MAOBDPP4LMNAMAPT
SCHEMBL7191866 0.89 ABCG2 (0.67) ABCG2MAOBDPP4LMNAMAPT
SCHEMBL7184299 0.89 ABCG2 (0.67) ABCG2MAOBDPP4LMNAMAPT
SCHEMBL9113183 0.88 MAOB (0.63) ABCG2MAOBDPP4LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed